[EN] OBJECTIVE The Diabetes Control and Complications Trial (DCCT) identified an inverse relationship between HbA(1c) and severe hypoglycemia. We investigated the relationship between hypoglycemia and HbA(1c) in a large type 1 diabetes cohort on multiple daily injection or insulin pump therapy using blinded continuous glucose monitoring (CGM) data. The impact of real-time CGM on these relationships and how these relationships differ with biochemical definitions of hypoglycemia have also been assessed. RESEARCH DESIGN AND METHODS CGM data were obtained from the JDRF CGM randomized control trial. Baseline blinded CGM data were used to assess time in hypoglycemia in all individuals. End point data fromthe CGMintervention group were used to ...
Abstract Background Glucose monitoring is vital for glycemic control in patients with diabetes melli...
BACKGROUND: Patients with type 1 diabetes who have impaired awareness of hypoglycaemia have a three ...
Aim: To identify responders to continuous glucose monitoring (CGM) in relation to reductions in HbA1...
OBJECTIVE: The Diabetes Control and Complications Trial identified an inverse relationship between H...
OBJECTIVE: The inverse relationship between overall glucose control and hypoglycemia risk is weakene...
Aims: We aimed to re-assess the previously shown but recently disputed association between HbA1c and...
Introduction: Both hypoglycemia (low blood glucose) and hyperglycemia (high blood glucose) are commo...
Background: Continuous glucose monitors (CGM) are becoming a norm for type 1 diabetes management and...
Aims Optimum therapy for patients with diabetes depends on both acute and long-term changes in plasm...
Aims: Optimum therapy for patients with diabetes depends on both acute and long-term changes in plas...
Aims Optimum therapy for patients with diabetes depends on both acute and long-term changes in plasm...
Aim To identify responders to continuous glucose monitoring (CGM) in relation to reductions in HbA1c...
Randomised controlled trials and other prospective clinical studies for novel medical interventions ...
Objective: In type 1 diabetes mellitus (T1DM) management, continuous glucose monitoring (CGM)-derive...
Introduction Studies have shown beneficial effects of real-time continuous glucose monitoring (rtCGM...
Abstract Background Glucose monitoring is vital for glycemic control in patients with diabetes melli...
BACKGROUND: Patients with type 1 diabetes who have impaired awareness of hypoglycaemia have a three ...
Aim: To identify responders to continuous glucose monitoring (CGM) in relation to reductions in HbA1...
OBJECTIVE: The Diabetes Control and Complications Trial identified an inverse relationship between H...
OBJECTIVE: The inverse relationship between overall glucose control and hypoglycemia risk is weakene...
Aims: We aimed to re-assess the previously shown but recently disputed association between HbA1c and...
Introduction: Both hypoglycemia (low blood glucose) and hyperglycemia (high blood glucose) are commo...
Background: Continuous glucose monitors (CGM) are becoming a norm for type 1 diabetes management and...
Aims Optimum therapy for patients with diabetes depends on both acute and long-term changes in plasm...
Aims: Optimum therapy for patients with diabetes depends on both acute and long-term changes in plas...
Aims Optimum therapy for patients with diabetes depends on both acute and long-term changes in plasm...
Aim To identify responders to continuous glucose monitoring (CGM) in relation to reductions in HbA1c...
Randomised controlled trials and other prospective clinical studies for novel medical interventions ...
Objective: In type 1 diabetes mellitus (T1DM) management, continuous glucose monitoring (CGM)-derive...
Introduction Studies have shown beneficial effects of real-time continuous glucose monitoring (rtCGM...
Abstract Background Glucose monitoring is vital for glycemic control in patients with diabetes melli...
BACKGROUND: Patients with type 1 diabetes who have impaired awareness of hypoglycaemia have a three ...
Aim: To identify responders to continuous glucose monitoring (CGM) in relation to reductions in HbA1...